Spring Day 2021
The UKMF Spring Day took place on Wednesday 17th March 2021. Thank you to our generous sponsors.
The theme for the meeting was the ‘Impact of Covid on MM management’ and we are were delighted to welcome the Michael Morley guest speaker Dr Maheshi Ramasamy from the University of Oxford who presented on ‘The Oxford Astra Zeneca vaccine – developing a global vaccine against COVID-19’.
Presentations for the meeting can be dowloaded below
Documents
- Spring Day 2021 Programme
- Amyloidosis Update
- The impact of COVID from a nursing perspective
- UK Myeloma Trial update
- Current management pathways for treatment of multiple myeloma
- Management of the Elderly and Frail Patient
- LLOGENEIC STEM CELL TRANSPLANTATION
- Auto or not
- Treatment of a young patient with a poor response to first line therapy
- Panobinostat in combination with Bortezomib and Dexamethasone (PAN-Vd) for Heavily Pre-treated Myeloma: A UK Real-World Multi-centre Cohort
- The Impact of Longitudinal Strain on Haematological and Cardiac Response and Survival in Patients with Systemic AL Amyloidosis
- Ocular Health of patients with Relapsed/Refractory Multiple Myeloma (RRMM): Baseline data from DREAMM-2 trial of Belantamab Mafadotin